El Paso, Tx—4/27/2023—Rio Grande Surgical Group today announced that Dr. Travis Mendel has been designated as a Center of Excellence for SpaceOAR™ Hydrogel – a device manufactured by Boston Scientific and designed to reduce the radiation dose delivered to the rectum during prostate cancer radiation treatment. Due to the rectum’s close proximity to the prostate, it can become unintentionally damaged during therapy, leading to issues with bowel function.1 SpaceOAR Hydrogel is designed to push the rectum away from the prostate, reducing the radiation dose delivered to the organ, which may lessen damage to the rectum.2 The Center of Excellence designation recognizes Dr. Travis Mendel’s with a high degree of experience applying SpaceOAR Hydrogel* and commitment to minimizing the impact on urinary, sexual and bowel quality of life for prostate cancer patients undergoing radiation therapy.3
Prostate cancer is the second most commonly diagnosed cancer in American men behind skin
Cancer, and more than 3.1 million living in the country have been diagnosed with the disease.4 Prostate cancer can be treated through several options, but each year, more than 60,000 patients treat their prostate cancer with radiation therapy, contributing to a nearly 100% five-year survival rate for individuals with the condition.4,5
“Being designated as a SpaceOAR Hydrogel Center of Excellence is an important recognition for us, and further supports our efforts to deliver the highest-quality treatment possible for prostate cancer patients in the El Paso area,” said Dr. Travis Mendel, Medical Director, Radiation Oncology. “Radiation therapy is an often-successful treatment option for individuals with prostate cancer, but some patients may remain hesitant due to the unintended side effects that can impact their quality-of-life following treatment. SpaceOAR Hydrogel can complement the patient’s radiation treatment to preserve healthy tissue and help maintain quality of life.”
SpaceOAR Hydrogel is made primarily of water and polyethylene glycol (PEG), a compound used in most
implants, and naturally leaves the body after approximately six months.2 A healthcare professional can implant SpaceOAR Hydrogel, a minimally invasive outpatient procedure, in an office, hospital, clinic or surgery center and, typically, patients can go back to normal activities soon after the procedure.6**
In addition to SpaceOAR Hydrogel, Rio Grande also offers SpaceOAR Vue™ Hydrogel, the next-generation of the device that can be seen on computerized tomography (CT) scans, negating the need for physicians to include magnetic resonance imaging (MRI) in treatment planning, and accommodating patients who are contra-indicated for MRI. SpaceOAR Vue Hydrogel is a radiopaque version of the technology designed to help physicians improve contouring accuracy and consistently position patients receiving prostate cancer radiation.
Clinical data has demonstrated the benefits of SpaceOAR Hydrogel, including a reduction in rectal injury, resulting in maintained bowel function and a higher likelihood of maintaining urinary and sexual function.6 SpaceOAR Hydrogel received 510(k) clearance from the FDA in 2015, and has been used in more than 150,000 procedures worldwide.7
For more information, visit SpaceOAR.com.
